Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Li-Fraumeni_syndrome
|
| gptkbp:age |
adults
|
| gptkbp:associated_with |
gptkb:Conn's_syndrome
gptkb:Company gptkb:Cushing's_syndrome hypertension adrenal insufficiency obesity |
| gptkbp:caused_by |
excess cortisol production
|
| gptkbp:gender |
more common in women
|
| gptkbp:genetic_diversity |
gptkb:Beckwith-Wiedemann_syndrome
gptkb:Multiple_Endocrine_Neoplasia_type_1 gptkb:Li-Fraumeni_syndrome |
| https://www.w3.org/2000/01/rdf-schema#label |
adrenal cortical carcinoma
|
| gptkbp:is_monitored_by |
imaging studies
hormone level tests regular follow-up exams |
| gptkbp:is_popular_in |
rare
|
| gptkbp:number_of_stages |
stage I
stage IV stage II stage III |
| gptkbp:occurs_in |
1-2 cases per million
|
| gptkbp:origin |
adrenal cortex
|
| gptkbp:outcome |
recurrence possible
metastasis possible survival rates vary |
| gptkbp:research |
ongoing clinical trials
|
| gptkbp:risk_factor |
family history
genetic mutations |
| gptkbp:scientific_classification |
gptkb:healthcare_organization
|
| gptkbp:social_responsibility |
gptkb:MRI
CT scan blood tests urine tests biopsy poor prognosis |
| gptkbp:symptoms |
fatigue
weight loss abdominal pain changes in mood muscle weakness high blood pressure skin changes menstrual irregularities hirsutism |
| gptkbp:treatment |
gptkb:hospital
gptkb:vaccine palliative care radiation therapy chemotherapy targeted therapy hormonal therapy clinical trials for new drugs |